mardi 29 avril 2014

Microfluidic technology reveals potential biomarker for early pancreatic cancer

The detection of pancreas cells in the blood may be an early sign of cancer, new research demonstrates. The findings suggest that circulating pancreas cells (CPCs) seed the bloodstream before tumors can be detected using current clinical tests such as CT and MRI scans, and that the detection of pancreas cells in the blood may be an early sign of cancer. Microfluidic technology reveals potential biomarker for early pancreatic cancer

Aucun commentaire:

Enregistrer un commentaire